Overview
Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991.
Dr. Campochiaro is rated as an Elite provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy.
His clinical research consists of co-authoring 156 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 86 articles and participated in 3 clinical trials in the study of Age-Related Macular Degeneration (ARMD).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1800 Orleans Street, Maumenee Lobby, Maumenee Lobby, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
The Johns Hopkins Hospital
Dr. Neil Bressler has been a member of the Wilmer Eye Institute's faculty since 1988 and is the inaugural James P. Gills Professor of Ophthalmology. He specializes in retinal diseases, with special interests in diabetic retinopathy and macular degeneration. Dr. Bressler's main research interests have been collaborative efforts in clinical trials of common retinal diseases, including age-related macular degeneration and diabetic retinopathy, having chaired several NIH-sponsored and industry-sponsored multicenter randomized clinical trials and authored almost 300 peer-reviewed publications. He is a past chair of the NIH-sponsored Diabetic Retinopathy Clinical Research Network, and was responsible for guidelines, policies, protocol development as well as implementation, and to facilitate Network operations in a way that maintains academic integrity and optimal clinical trial performance. He also has chaired the National Eye Institutes Data and Safety Monitoring Committee for intramural clinical trials and the FDA Ophthalmic Devices Panel. Dr. Bressler is currently editor-in-chief of JAMA Ophthalmology. Dr. Bressler is rated as an Elite provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.
Emily Chew is an Ophthalmologist in Bethesda, Maryland. Dr. Chew is rated as an Elite provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). Her top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Diabetic Retinopathy, and Cataract Removal.
Tiarnan Keenan is an Ophthalmologist in Bethesda, Maryland. Dr. Keenan is rated as a Distinguished provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Geographic Atrophy, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Von Hippel-Lindau (VHL) Syndrome, and Cataract Removal.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Age-Related Macular Degeneration (ARMD)
- Diabetic Macular Edema (DME)Dr. Campochiaro isElite. Learn about Diabetic Macular Edema (DME).
- Late-Onset Retinal DegenerationDr. Campochiaro isElite. Learn about Late-Onset Retinal Degeneration.
- Retinal Vein OcclusionDr. Campochiaro isElite. Learn about Retinal Vein Occlusion.
- Retinitis PigmentosaDr. Campochiaro isElite. Learn about Retinitis Pigmentosa.
- Retinopathy Pigmentary Mental Retardation
- Distinguished
- Diabetic RetinopathyDr. Campochiaro isDistinguished. Learn about Diabetic Retinopathy.
- Retinal DetachmentDr. Campochiaro isDistinguished. Learn about Retinal Detachment.
- Advanced
- Cone DystrophyDr. Campochiaro isAdvanced. Learn about Cone Dystrophy.
- Cone Rod Dystrophy Amelogenesis ImperfectaDr. Campochiaro isAdvanced. Learn about Cone Rod Dystrophy Amelogenesis Imperfecta.
- Cone-Rod DystrophyDr. Campochiaro isAdvanced. Learn about Cone-Rod Dystrophy.
- Doyne Honeycomb Retinal DystrophyDr. Campochiaro isAdvanced. Learn about Doyne Honeycomb Retinal Dystrophy.
- EndophthalmitisDr. Campochiaro isAdvanced. Learn about Endophthalmitis.
- Stargardt Macular DegenerationDr. Campochiaro isAdvanced. Learn about Stargardt Macular Degeneration.
- Experienced
- Adult-Onset Vitelliform Macular Dystrophy (AVMD)Dr. Campochiaro isExperienced. Learn about Adult-Onset Vitelliform Macular Dystrophy (AVMD).
- CataractDr. Campochiaro isExperienced. Learn about Cataract.
- Cataract RemovalDr. Campochiaro isExperienced. Learn about Cataract Removal.
- Choroid Plexus CarcinomaDr. Campochiaro isExperienced. Learn about Choroid Plexus Carcinoma.
- Geographic AtrophyDr. Campochiaro isExperienced. Learn about Geographic Atrophy.
- GlaucomaDr. Campochiaro isExperienced. Learn about Glaucoma.